Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC awarded NIH grant as part of nationwide effort to seek, test and treat inmates with HIV
Investigators at the University of North Carolina at Chapel Hill comprise one of 12 scientific teams in more than a dozen states which will receive National Institutes of Health (NIH) grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system.
Located in Vital Signs / 2010 / Sept. 30
Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner
These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.
Located in News / 2015 / July
Thomas Belhorn, MD, PhD
Thomas Belhorn, MD, PhD is an associate professor in the Department of Pediatrics and an expert in Pediatric infectious diseases, viral infections, HIV, medical education.
Located in For the Media / Experts Guide
Myron S. Cohen, MD
Myron S. Cohen, MD is the Division Chief and Director in the UNC Center for Infectious Diseases. He is also a J. Herbert Bate Distinguished Professor in the Department of Medicine. He is an expert in sexually transmitted diseases and HIV, biology and epidemiology.
Located in For the Media / Experts Guide
Peter A. Leone, MD
Peter A. Leone, MD, is a professor in the Department of Medicine and is an expert in the diagnosis and treatment of sexually transmitted diseases.
Located in For the Media / Experts Guide
Surprise Finding About HIV Reservoir Could Lead to Better Therapies
Researchers led by Ron Swanstrom, PhD, and colleagues in South Africa, discovered that the latent HIV reservoir that persists during antiretroviral treatment mostly reflects viruses present in the blood at the start of antiretroviral treatment.
Located in News / 2019 / October
Long-acting injectable implant shows promise for HIV treatment and prevention
The long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers Rahima Benhabbour, PhD and Martina Kovarova, PhD, is injected under the skin and forms into a solid implant that dissolves slowly to release anti-HIV medication over time.
Located in News / 2018 / October
Funding Announcement: Center for AIDS Research
The Center for AIDS Research (CFAR) has several internal developmental grants available to HIV and related investigators.
Located in Vital Signs / 2008 / December
Preventing HPV might lower risk of HIV infection in men
Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.
Located in Vital Signs / 2010 / Vital Signs - May 13, 2010
UNC Physician Receives 2009 International Leadership Award From The Elizabeth Glaser Pediatric AIDS Foundation
Agnes Moses, MD has been selected to receive the 2009 International Leadership Award (ILA) from The Elizabeth Glaser Pediatric AIDS Foundation.
Located in Vital Signs / Archives / Vital Signs - July 31, 2009